Onyx-3, a double-blind comparison of once- or twice-daily dosing with YM150 (30 or 60 mg daily) for preventing venous thromboembolism after elective hip arthroplasty Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • July 1, 2011